Which drugs are currently considered the main treatment for attention-deficit hyperactivity disorder (ADHD)?

The main treatment for attention-deficit hyperactivity disorder (ADHD) primarily involves stimulant medications, which enhance the levels of certain neurotransmitters in the brain that help improve focus, attention, and impulse control. Methylphenidate (often known by the brand name Ritalin) and dextroamphetamine (often marketed as Dexedrine) are two of the most commonly prescribed stimulant medications for ADHD. These drugs have been extensively researched and are recognized for their effectiveness in managing the symptoms of ADHD.

The choice of methylphenidate and dextroamphetamine is rooted in a long-standing history of clinical use and empirical evidence supporting their efficacy. By increasing dopamine and norepinephrine levels in the brain, they help improve concentration and reduce hyperactive and impulsive behaviors that are characteristic of ADHD.

Other options listed do not align with the standard pharmacological treatments for ADHD. Antipsychotics and mood stabilizers, while useful for various mental health issues, are typically not first-line treatments for ADHD. Similarly, selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines target different symptoms and conditions and are not indicated for ADHD treatment. Non-stimulant alternatives exist, such as atomoxetine, but these are generally considered after